Showing results (11-20 of 9,198) with videos related to
Sort By:
Pageof 920
The International Journal of Neuropsychopharmacology|March 17, 2016
A Phase II Dose-Ranging Study Evaluating the Efficacy and Safety of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Primary InsomniaKathryn M Connor, Erin Mahoney, Saheeda Jackson, et al.The International Journal of Neuropsychopharmacology|June 6, 2017
Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive DisorderKathryn M Connor, Paulette Ceesay, Jill Hutzelmann, et al.Human Psychopharmacology|March 28, 2013
Randomized controlled study of the T-type calcium channel antagonist MK-8998 for the treatment of acute psychosis in patients with schizophreniaMichael F Egan, Xin Zhao, Andrew Smith, et al.Regulatory Toxicology and Pharmacology : RTP|October 6, 2024
Safety assessment of drug impurities for patient safety: A comprehensive reviewFrank LiuCytotherapy|May 7, 2024
The science and practice of current environmental risk assessment for gene therapy: a reviewFrank LiuToxicology Letters|August 31, 2025
Safety assessment of endotoxin related to drug products and medical devices: A reviewFrank LiuCritical Reviews in Oncology/Hematology|July 27, 2025
Safety assessment of antibody-drug conjugates: Nonclinical toxicology, non-active ingredients, and environmental risk considerationsFrank LiuPharmaceutical Statistics|November 11, 2017
A dynamic power prior for borrowing historical data in noninferiority trials with binary endpointG Frank LiuCurrent Research in Toxicology|July 8, 2024
Visible particles in parenteral drug products: A review of current safety assessment practiceFrank Liu, Richard HutchinsonRegulatory Toxicology and Pharmacology : RTP|March 29, 2026
10-step systemic safety assessment of extractables and leachables associated with drug products integrating topline, traditional, and next generation risk assessmentFrank Liu, Albert LiuPageof 920